In the preeclampsia group, two central genes of this pathway, namely the EGF-receptor and the myocyte enhancer factor 2 (MEF2), were hypomethylated, suggesting that a change in gene products and thus activation of the pathway is possible under the stressor preeclampsia. Here, MEF2A is linked to preeclampsia.